Approval · Notice of Compliance 28610 · 2022
OCALIVA: Notice of Compliance 28610
Issued July 18, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28610
- Date
- July 18, 2022
- Company
- Intercept Pharma Canada Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
Medicinal ingredients
- OBETICHOLIC ACID 10 MG per TAB
- OBETICHOLIC ACID 5 MG per TAB